9.00
-0.69 (-7.12%)
| Penutupan Terdahulu | 9.69 |
| Buka | 8.39 |
| Jumlah Dagangan | 6,353,312 |
| Purata Dagangan (3B) | 2,650,943 |
| Modal Pasaran | 1,137,600,000 |
| Harga / Pendapatan (P/E Ke hadapan) | 21.83 |
| Harga / Jualan (P/S) | 0.500 |
| Harga / Buku (P/B) | 1.24 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Nov 2025 |
| Margin Keuntungan | -4.54% |
| Margin Operasi (TTM) | 0.35% |
| EPS Cair (TTM) | -1.23 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -24.40% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 77.09% |
| Nisbah Semasa (MRQ) | 0.990 |
| Aliran Tunai Operasi (OCF TTM) | 18.42 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 2.23 M |
| Pulangan Atas Aset (ROA TTM) | -0.04% |
| Pulangan Atas Ekuiti (ROE TTM) | -9.24% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Health Information Services (US) | Menaik | Bercampur |
| Health Information Services (Global) | Menaik | Bercampur | |
| Stok | Evolent Health, Inc | Menaik | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | 3.0 |
| Purata | 1.25 |
|
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services. |
|
| Sektor | Healthcare |
| Industri | Health Information Services |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 1.55% |
| % Dimiliki oleh Institusi | 108.63% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Cadian Capital Management, Lp | 31 Mar 2025 | 10,794,606 |
| Camber Capital Management Lp | 31 Mar 2025 | 3,000,000 |
| Rock Springs Capital Management Lp | 31 Mar 2025 | 2,695,700 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 18.00 (Piper Sandler, 100.00%) | Beli |
| Median | 16.00 (77.78%) | |
| Rendah | 13.00 (JMP Securities, 44.44%) | Beli |
| Purata | 15.67 (74.11%) | |
| Jumlah | 3 Beli | |
| Harga Purata @ Panggilan | 10.05 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Piper Sandler | 28 Aug 2025 | 18.00 (100.00%) | Beli | 9.64 |
| Truist Securities | 17 Jul 2025 | 16.00 (77.78%) | Beli | 11.27 |
| JMP Securities | 20 Jun 2025 | 13.00 (44.44%) | Beli | 9.25 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 19 Aug 2025 | Pengumuman | Evolent Health, Inc. Announces Pricing of Oversubscribed and Upsized $145.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock |
| 18 Aug 2025 | Pengumuman | Evolent Health, Inc. Announces Proposed Offering of $140.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock |
| 07 Aug 2025 | Pengumuman | Evolent Announces Second Quarter 2025 Results |
| 14 Jul 2025 | Pengumuman | Evolent To Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025 |
| 09 Jul 2025 | Pengumuman | Evolent announces key appointments to leadership team |
| 20 Jun 2025 | Pengumuman | Evolent reiterates Q2 and full year guidance for Adjusted EBITDA |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |